
Utah Medical Products, Inc.: updates and filings
Price
$70.96
November 19, 2026Market cap $226M
What Ploutos Investor adds for Utah Medical Products
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Oct 22, 2026next Jan 22, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
October 2026
May 2026
January 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 13, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 3, 2026Other material eventsForm8-K
- Oct 29, 2026SCHEDULE TO-I/A (amendment)FormSC TO-I/A
- Oct 22, 2026Results of operationsForm8-K
- Oct 5, 2026SCHEDULE TO-I/A (amendment)FormSC TO-I/A
- Sep 29, 2026SCHEDULE TO-I/A (amendment)FormSC TO-I/A
- Sep 25, 2026SCHEDULE TO-CFormSC TO-C
- Sep 24, 2026SCHEDULE TO-CFormSC TO-C
- Sep 24, 2026FilingFormSC TO-I
- Sep 17, 2026FORM SC TO-CFormSC TO-C
- Aug 31, 2026Regulation FD disclosureForm8-K
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 12, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 23, 2026Results of operationsForm8-K
- May 27, 2026Conflict minerals reportFormSD
- May 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 12, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 4, 2026Shareholder voteForm8-K
- Apr 23, 2026Results of operationsForm8-K
- Apr 2, 2026Annual meeting proxy statementFormDEF 14A
- Mar 27, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jan 29, 2026Results of operationsForm8-K
- Nov 14, 2025Quarterly reportfor the period to Sep 30, 2025Form10-Q
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 13, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 3, 2026 | 8-K | Other material events | Document |
| Oct 29, 2026 | SC TO-I/A | SCHEDULE TO-I/A (amendment) | Document |
| Oct 22, 2026 | 8-K | Results of operations | Document |
| Oct 5, 2026 | SC TO-I/A | SCHEDULE TO-I/A (amendment) | Document |
| Sep 29, 2026 | SC TO-I/A | SCHEDULE TO-I/A (amendment) | Document |
| Sep 25, 2026 | SC TO-C | SCHEDULE TO-C | Document |
| Sep 24, 2026 | SC TO-C | SCHEDULE TO-C | Document |
| Sep 24, 2026 | SC TO-I | Filing | Document |
| Sep 17, 2026 | SC TO-C | FORM SC TO-C | Document |
| Aug 31, 2026 | 8-K | Regulation FD disclosure | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 12, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 23, 2026 | 8-K | Results of operations | Document |
| May 27, 2026 | SD | Conflict minerals report | Document |
| May 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 12, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 4, 2026 | 8-K | Shareholder vote | Document |
| Apr 23, 2026 | 8-K | Results of operations | Document |
| Apr 2, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 27, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jan 29, 2026 | 8-K | Results of operations | Document |
| Nov 14, 2025 | 10-Q | Quarterly reportfor the period to Sep 30, 2025 | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Feb 14, 1994.
The full analysis
What do Utah Medical Products's filings show?
The filings are where every one of Utah Medical Products's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.